Research Options:

Week of Expected Pricing 10/29/2024
Company Name POLYRIZON LTD
Proposed Ticker PLRZ
CUSIP M79549107
Business Description We are a development stage biotech company specializing in the development of innovative medical device hydrogels delivered in the form of nasal sprays, which form a thin hydrogel-based shield containment barrier in the nasal cavity that can provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. Our proprietary Capture and Contain™, or C&C, hydrogel technology, comprised of a mixture of naturally occurring building blocks, is delivered in the form of nasal sprays, and potentially functions as a “biological mask” with a thin shield containment barrier in the nasal cavity. We are further developing certain aspects of our C&C hydrogel technology such as the bioadhesion and prolonged retention at the nasal deposition site for intranasal delivery of drugs. We refer to our additional technology, which is in an earlier stage of pre-clinical development, that is focused on nasal delivery of active pharmaceutical ingredients, or APIs, as Trap and Target™, or T&T.
Lead Underwriter Aegis Capital Corp.
Co-Managers N/A
Initial Shares 958,903
Revised Initial Shares N/A
Initial Price $4.38-$4.38
Revised Price N/A
Final Price $4.38
Final Ticker PLRZ

 

 

   
  © 2024 ICE Data Services. All rights reserved.